Is traveler's diarrhea a significant risk factor for the development of irritable bowel syndrome? A prospective study

被引:86
作者
Stermer, Edy
Lubezky, Anat
Potasman, Israel
Paster, Eran
Lavy, Alexandra
机构
[1] Bnai Zion Med Ctr, Serv Gastroenterol, Haifa, Israel
[2] Bnai Zion Med Ctr, Infect Dis & Travel Med, Haifa, Israel
[3] Technion Israel Inst Technol, Rappaport Fac Med, IL-31096 Haifa, Israel
关键词
D O I
10.1086/507540
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A total of 564 travelers were enrolled in a study aimed at investigating the influence of traveler's diarrhea in the development of irritable bowel syndrome. At 6-7 months after repatriation, we found that an episode of traveler's diarrhea was associated with a quintuple risk of developing irritable bowel syndrome.
引用
收藏
页码:898 / 901
页数:4
相关论文
共 21 条
[1]  
Barbara G, 2000, ALIMENT PHARM THERAP, V14, P1127
[2]  
CHAUDHARY NA, 1962, Q J MED, V31, P307
[3]   Sequelae of traveler's diarrhea: Focus on postinfectious irritable bowel syndrome [J].
Connor, BA .
CLINICAL INFECTIOUS DISEASES, 2005, 41 :S577-S586
[4]   Irritable bowel syndrome: Epidemiology, natural history, health care seeking and emerging risk factors [J].
Cremonini, F ;
Talley, NJ .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2005, 34 (02) :189-+
[5]   Giardia lamblia infections become clinically evident by eliciting symptoms of irritable bowel syndrome [J].
D'Anchino, M ;
Orlando, D ;
De Feudis, L .
JOURNAL OF INFECTION, 2002, 45 (03) :169-172
[6]   A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea [J].
DuPont, HL ;
Jiang, ZD ;
Okhuysen, PC ;
Ericsson, CD ;
de la Cabada, FJ ;
Ke, S ;
DuPont, MW ;
Martinez-Sandoval, F .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (10) :805-812
[7]  
EAMONN MMQ, 2006, WORLD J GASTROENTERO, V12, P1
[8]  
Feldman M., 2002, SLEISENGER FORDTRANS, V7
[9]  
Gomez-Escudero Octavio, 2003, Rev Gastroenterol Mex, V68, P55
[10]  
GOMEZESCUDERO O, 2003, REV GASTROENTEROL ME, V68, P58